Quest Diagnostics (NYSE:DGX) announced a US$500 million senior notes offering. The company also entered a multi year clinical ...

Quest Diagnostics delivered first quarter results that exceeded Wall Street’s revenue and profit expectations, driven by ...

Quest Diagnostics Incorporated DGX on Tuesday reported first-quarter adjusted earnings of $2.50 per share, beating the ...

Quest Diagnostics Incorporated (NYSE: DGX) (the "Company"), a leader in diagnostic information services, today announced the ...

For both the three months ended March 31, 2026 and 2025, the pre-tax impact represents costs primarily associated with ...

Quest Diagnostics is rated a Buy driven by demographic tailwinds, improving reimbursement, and disciplined capital returns.

SECAUCUS, N.J., March 19, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report first quarter 2026 financial ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...